Covid Vaccine Studies out for Cancer Patients

This topic contains 1 reply, has 2 voices, and was last updated by  JohnKelly 3 years, 4 months ago.

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #142273

    sachbarnes
    Participant

    Hi, I have seen quite a few articles online in the last few weeks about Study results for Vaccine efficacy in Cancer patients.

    Has anyone spoken to their Consultant recently on testing for antibodies etc, as for some with Myeloma there can be no antibody response to 2 doses, so extra shielding might be recommended until a booster.

    Tx.

    • This topic was modified 3 years, 4 months ago by  sachbarnes.
    #142304

    JohnKelly
    Participant

    I got an antibody test, which showed a response, but at a very low level (2.8 U/mL, this after 2 jabs of AZ). My consultant’s response to the test results was to go through the reassuring arguments that say we don’t yet know exactly what this implies – T cells may be OK, etc. He did not give any advice about shielding. But my own conclusion is that I have to act as though I am largely unprotected. My hope was to press for priority on booster jab – but it seems that this cannot be done until the Government guidelines are updated.

    Meanwhile, the prevalence of the infection is increasing, the delta variant is 2x as infectious as initial variant in 2020, so I think the risk for those without protection of effective vaccination is about as high as it has ever been. But if anyone is giving advice about shielding, it is lost in the general national euphoria about unlocking. I’m not against the general unlocking, but if things are as risky as I suspect for blood cancer sufferers, I think clear advice is required urgently.

Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.